DSP Nifty Healthcare ETF

A Other ETF scheme from DSP Mutual Fund. Figures below are for the Regular · option not stated plan (ISIN INF740KA1ZG1).

NAV ₹17.3328 on 16 November 2026.

Expense ratio

Total expense ratio 0.23% a year for the Regular · option not stated plan, as AMFI published it on 29 October 2026: base expense ratio 0.17%, brokerage 0.00%, transaction costs 0.00%, statutory levies including GST 0.06%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year-88.7%92.5%-90.5%-1.04-0.75

Too little NAV history for the 3, 5, 10-year figures.

Not ranked in its category: its category mixes funds too different to rank against one another.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 99.9% of the portfolio.

  1. Sun Pharmaceutical Industries Limited — 16.31%
  2. Divi's Laboratories Limited — 10.77%
  3. Laurus Labs Limited — 8.12%
  4. Apollo Hospitals Enterprise Limited — 7.53%
  5. Dr. Reddy's Laboratories Limited — 7.15%
  6. Cipla Limited — 6.73%
  7. Torrent Pharmaceuticals Limited — 5.88%
  8. Max Healthcare Institute Limited — 5.55%
  9. Lupin Limited — 4.23%
  10. Aurobindo Pharma Limited — 4.03%

Plans

Other funds in Other ETF

All 232 funds in Other ETF · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.